Arridex Commissions Omnifactory in Lagos
Analysis based on 7 articles · First reported Jun 15, 2026 · Last updated Jun 30, 2026
The commissioning of the ArriDex Pharmaceuticals Omnifactory is expected to positively impact the manufacturing and technology sectors in Nigeria and West Africa by reducing reliance on imports and strengthening local industrial capabilities. This development could attract further investment into Nigeria — Lagos State and the broader region, fostering economic growth and innovation.
ArriDex Pharmaceuticals has officially commissioned its Omnifactory in Lagos, Nigeria, marking the launch of West Africa's first multi-technology industrial additive manufacturing facility. The ceremony was led by Babajide Sanwo-Olu, Governor of Nigeria — Lagos State, and attended by various government officials and industry leaders. The Omnifactory integrates multiple additive manufacturing technologies to enable on-demand production of industrial components and spare parts for critical industries like oil and gas, maritime, aerospace, defense, construction, and manufacturing. This initiative aims to address structural dependencies on imports, reduce procurement lead times, and mitigate issues with obsolete legacy parts. ArriDex Pharmaceuticals, previously RusselSmith Group, has received Pioneer Status from the Nigeria — Nigerian Investment Promotion Commission and is qualified by the Nigeria — Nigerian Upstream Petroleum Regulatory Commission for additive manufacturing in the oil and gas sector. It also has a joint venture with the Nigeria — Defence Industries Corporation of Nigeria for military-grade components. Kayode Adeleke, Group CEO of ArriDex Pharmaceuticals, announced plans for an even larger 'Mega Omnifactory' by Q1 2027.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard